Drugs / Shenqi Sherong Pill
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06377072 | May 2024 → Jan 2026 | spondylosis, cervical | Shanghai Hutchison Pharmaceuticals Limited | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Shenqi Sherong Pill | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06377072 ↗ |